The SOLAR-RECUR trial evaluates copper Cu 64 PSMA I&T PET/CT for detecting biochemical recurrence in prostate cancer post-treatment. The trial enrolled 235 patients, focusing on detection and ...

Emory Urology's residency program is one of the largest in the U.S., offering diverse training across multiple hospital sites. Residents gain extensive clinical experience through rotations in ...

“Our study is distinguished by long follow-up, out to 12 years, looking at a broad spectrum of key complications," says Joseph M. Unger, PhD.

The revised policy will take effect on January 1, 2025.

"I joke that on face value, the APPs work for me, but I feel like I'm really working for them, because they basically do everything except for the surgery," says Andrew Y. Sun, MD.

Enzalutamide plus GnRH significantly improved metastasis-free survival in nmCSPC patients with high BCR risk compared to monotherapies. The study population included patients with PSA doubling time ≤ ...

Tailor the program to available resources and staff, ensuring it fits the specific practice environment. Consistent patient-provider interactions enhance patient experience, though not always possible ...

New robotic systems, like CMR and Medtronic's Hugo, are entering the market, increasing competition and innovation in robotic surgery. The da Vinci 5 robot offers incremental improvements, such as ...

The artificial urinary sphincter significantly improves mental health by reducing anxiety, depression, and enhancing self-esteem in men with stress urinary incontinence. Post-treatment, urinary ...

The TENACIO Pump's smaller design and pronounced decompression mechanism improve patient interaction with the implant. Helen L. Bernie reports no challenges in implanting the AMS 700 with TENACIO Pump ...

In this video, Kara Cossis, PA-C, MPH, discusses the role of advanced practice providers (APPs) in expanding and encouraging the use of genetic testing for prostate cancer. Cossis is a physician ...

“Prostate cancer patients with life expectancies of less than 5 or 10 years were being subjected to treatments that can take up to a decade to significantly improve their chances of surviving cancer, ...